Literature DB >> 12679348

Prolongation of the laryngeal chemoreflex after inhibition of the rostral ventral medulla in piglets: a role in SIDS?

Liesbeth Van Der Velde1, Aidan K Curran, James J Filiano, Robert A Darnall, Donald Bartlett, J C Leiter.   

Abstract

We tested the hypothesis that inhibition of neurons within the rostral ventral medulla (RVM) would prolong the laryngeal chemoreflex (LCR), a putative stimulus in the sudden infant death syndrome (SIDS). We studied the LCR in 19 piglets, age 3-16 days, by injecting 0.05 ml of saline or water into the larynx during wakefulness, non-rapid eye movement (NREM) sleep, and REM sleep, before and after 1 or 10 mM muscimol dialysis in the RVM. Muscimol prolonged the LCR (P < 0.05), and the prolongation was greater when the LCR was stimulated with water compared with saline (P < 0.02). The LCR was longer during NREM sleep than during wakefulness and longest during REM sleep (REM compared with wakefulness). Muscimol had no effect on the likelihood of arousal from sleep after LCR stimulation. We conclude that the RVM provides a tonic facilitatory drive to ventilation that limits the duration of the LCR, and loss of this drive may contribute to the SIDS when combined with stimuli that inhibit respiration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679348     DOI: 10.1152/japplphysiol.01103.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  20 in total

1.  TRPV1 channels in the nucleus of the solitary tract mediate thermal prolongation of the LCR in decerebrate piglets.

Authors:  Luxi Xia; Donald Bartlett; J C Leiter
Journal:  Respir Physiol Neurobiol       Date:  2011-01-27       Impact factor: 1.931

2.  Effects of postnatal smoke exposure on laryngeal chemoreflexes in newborn lambs.

Authors:  Marie St-Hilaire; Charles Duvareille; Olivier Avoine; Anne-Marie Carreau; Nathalie Samson; Philippe Micheau; Alexandre Doueik; Jean-Paul Praud
Journal:  J Appl Physiol (1985)       Date:  2010-09-23

3.  Interleukin-1β and interleukin-6 enhance thermal prolongation of the LCR in decerebrate piglets.

Authors:  Luxi Xia; Donald Bartlett; J C Leiter
Journal:  Respir Physiol Neurobiol       Date:  2016-05-12       Impact factor: 1.931

4.  Decreased GABAA receptor binding in the medullary serotonergic system in the sudden infant death syndrome.

Authors:  Kevin G Broadbelt; David S Paterson; Richard A Belliveau; Felicia L Trachtenberg; Elisabeth A Haas; Christina Stanley; Henry F Krous; Hannah C Kinney
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

Review 5.  The Serotonin Brainstem Hypothesis for the Sudden Infant Death Syndrome.

Authors:  Hannah C Kinney; Robin L Haynes
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

6.  Gestational cigarette smoke exposure and hyperthermic enhancement of laryngeal chemoreflex in rat pups.

Authors:  Luxi Xia; Mardi Crane-Godreau; James C Leiter; Donald Bartlett
Journal:  Respir Physiol Neurobiol       Date:  2008-11-12       Impact factor: 1.931

7.  Neuroanatomic relationships between the GABAergic and serotonergic systems in the developing human medulla.

Authors:  Kevin G Broadbelt; David S Paterson; Keith D Rivera; Felicia L Trachtenberg; Hannah C Kinney
Journal:  Auton Neurosci       Date:  2009-11-17       Impact factor: 3.145

8.  Laryngeal reflex apnea in neonates: effects of CO2 and the complex influence of hypoxia.

Authors:  L Xia; J C Leiter; D Bartlett
Journal:  Respir Physiol Neurobiol       Date:  2013-01-22       Impact factor: 1.931

Review 9.  The brainstem and serotonin in the sudden infant death syndrome.

Authors:  Hannah C Kinney; George B Richerson; Susan M Dymecki; Robert A Darnall; Eugene E Nattie
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

10.  Serotonin in the solitary tract nucleus shortens the laryngeal chemoreflex in anaesthetized neonatal rats.

Authors:  William T Donnelly; Donald Bartlett; J C Leiter
Journal:  Exp Physiol       Date:  2016-06-12       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.